Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.

[1]  A. Larsson,et al.  Pentraxin 3 Increase is Much Less Pronounced Than C-Reactive Protein Increase After Surgical Procedures , 2011, Inflammation.

[2]  I. D. de Boer,et al.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  W. Ryu,et al.  Effects of low serum triglyceride on stroke mortality: a prospective follow-up study. , 2010, Atherosclerosis.

[4]  Sung-il Cho,et al.  Increases in body mass index over a 7-year period and risk of cause-specific mortality in Korean men. , 2010, International journal of epidemiology.

[5]  C. Garlanda,et al.  The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. , 2010, Trends in cardiovascular medicine.

[6]  A. Gass,et al.  Copeptin: A novel, independent prognostic marker in patients with ischemic stroke , 2009, Annals of neurology.

[7]  Kwang-Soo Lee,et al.  Relationship between High-Sensitivity C-Reactive Protein and Clinical Functional Outcome after Acute Ischemic Stroke in a Korean Population , 2009, Cerebrovascular Diseases.

[8]  L. Kuller,et al.  Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause Death: The Cardiovascular Health Study , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[9]  K. Node,et al.  Prognostic value of pentraxin 3 in patients with chronic heart failure. , 2008, International journal of cardiology.

[10]  J. Carrero,et al.  Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[11]  I. Kubota,et al.  Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. , 2007, American heart journal.

[12]  T. Kodama,et al.  Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[13]  F. Aichner,et al.  Admission C-reactive protein as a predictor for stroke outcome among candidates for thrombolysis: decision adjourned. , 2006, Stroke.

[14]  Sun Ha Jee,et al.  Body-mass index and mortality in Korean men and women. , 2006, The New England journal of medicine.

[15]  Gianni Tognoni,et al.  Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction , 2004, Circulation.

[16]  A. Mantovani,et al.  Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. , 2004, Atherosclerosis.

[17]  V. Feigin,et al.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.

[18]  C. Garlanda,et al.  Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[19]  G Olivetti,et al.  PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. , 2000, Circulation.

[20]  Francesco Tedesco,et al.  Multimer Formation and Ligand Recognition by the Long Pentraxin PTX3 , 1997, The Journal of Biological Chemistry.

[21]  J. Garthwaite,et al.  Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke , 1997, Annals of clinical biochemistry.

[22]  Barbara Bottazzi,et al.  Pentraxins in Innate Immunity: From C-Reactive Protein to the Long Pentraxin PTX3 , 2007, Journal of Clinical Immunology.

[23]  C. Garlanda,et al.  Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. , 2005, Annual review of immunology.

[24]  M. Di Napoli,et al.  C-reactive protein and outcome after first-ever ischemic stroke. , 2000, Stroke.